|
|
Vaccine Detail
|
influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] |
| Vaccine Information |
- Vaccine Name: influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023]
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Tradename: Flucelvax Quadrivalent 2022-2023
- Vaccine Ontology ID: VO_0021102
- Type: Inactivated or "killed" vaccine
- Host Species for Licensed Use: Human
|
| Host Response |
|
|
| References |
|
|
|
